Zheng et al. demonstrated that post-recurrent STS (including LPS) exhibited significantly elevated levels of PD-L1+ tumor cells and lymphocytes compared to STS at primary diagnosis while the amount of CD8+ T cells decreased [143]. The gene discussed is CD8A; the disease is telomere syndrome.